We are live on
!
Find out more
CM
Caption Management Portfolio holdings
AUM
$17.1B
1-Year Est. Return
70.99%
This Fund
S&P 500
This Quarter
Est. Return
+4.28%
1 Year Est. Return
+70.99%
3 Year Est. Return
+176.06%
5 Year Est. Return
+263.89%
10 Year Est. Return
–
AUM
$1.99B
AUM Growth
+$172M
(+9.5%)
Cap. Flow
+$156M
Cap. Flow
% of AUM
7.83%
Top 10 Holdings %
Top 10 Hldgs %
16.27%
Holding
935
New
395
Increased
92
Reduced
99
Closed
294
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
+$8.42M |
| 2 |
Marathon Petroleum
MPC
|
+$5.47M |
| 3 |
Liberty Global Class C
LBTYK
|
+$5.39M |
| 4 |
O'Reilly Automotive
ORLY
|
+$5.32M |
| 5 |
Crocs
CROX
|
+$5.07M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$12.6M |
| 2 |
Tapestry
TPR
|
+$12M |
| 3 |
iShares MSCI Saudi Arabia ETF
KSA
|
+$8.32M |
| 4 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$6.96M |
| 5 |
SAGE
Sage Therapeutics
SAGE
|
+$6.93M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.95% |
| 2 | Consumer Discretionary | 2.51% |
| 3 | Technology | 1.96% |
| 4 | Energy | 1.43% |
| 5 | Communication Services | 1.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
CALL
G-III Apparel Group
GIII
$1.54B
| $515K | 0.03% |
+17,500
| New | +$597K |
|
|
ODP
477
DELISTED
ODP
ODP
| $515K | 0.03% |
+25,000
| New | +$566K |
|
478
CALL
Ovintiv
OVV
$17.3B
| $513K | 0.03% |
+20,000
| New | +$624K |
|
479
Southwest Airlines
LUV
$22B
| $507K | 0.03% |
+10,000
| New | +$518K |
|
|
AVEO
480
CALL
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $503K | 0.03% |
74,820
-10,700
| -13% | -$91.7K |
|
|
ISBC
481
CALL
DELISTED
Investors Bancorp, Inc.
ISBC
| $502K | 0.03% |
+45,000
| New | +$510K |
|
482
CALL
VICI Properties
VICI
$29B
| $501K | 0.03% |
+22,700
| New | +$507K |
|
483
CALL
Plains GP Holdings
PAGP
$5.21B
| $499K | 0.03% |
+20,000
| New | +$483K |
|
484
Tenet Healthcare
THC
$20.5B
| $496K | 0.03% |
24,000
-15,000
| -38% | -$346K |
|
|
MNTV
485
DELISTED
Momentive Global Inc. Common Stock
MNTV
| $495K | 0.02% |
30,000
-20,000
| -40% | -$342K |
|
486
Okta
OKTA
$24.7B
| $493K | 0.02% |
+4,000
| New | +$434K |
|
487
PUT
Plains All American Pipeline
PAA
$17.3B
| $487K | 0.02% |
+20,000
| New | +$477K |
|
|
IAA
488
CALL
DELISTED
IAA, Inc. Common Stock
IAA
| $485K | 0.02% |
+12,500
| New | +$485K |
|
489
PUT
CRA International
CRAI
$1.16B
| $478K | 0.02% |
+12,500
| New | +$540K |
|
490
Regeneron Pharmaceuticals
REGN
$78.5B
| $469K | 0.02% |
+1,500
| New | +$499K |
|
491
American Eagle Outfitters
AEO
$2.88B
| $465K | 0.02% |
+27,500
| New | +$557K |
|
492
Heron Therapeutics
HRTX
$93.9M
| $465K | 0.02% |
25,000
-12,200
| -33% | -$244K |
|
|
ARQL
493
DELISTED
Arqule Inc
ARQL
| $455K | 0.02% |
+41,400
| New | +$288K |
|
494
TIM SA
TIMB
$9.16B
| $449K | 0.02% |
+30,000
| New | +$435K |
|
495
CALL
Corcept Therapeutics
CORT
$12.4B
| $446K | 0.02% |
40,000
+20,000
| +100% | +$223K |
|
|
496
Corcept Therapeutics
CORT
$12.4B
| $446K | 0.02% |
40,000
+33,100
| +480% | +$369K |
|
|
497
PUT
Corcept Therapeutics
CORT
$12.4B
| $446K | 0.02% |
40,000
+20,000
| +100% | +$223K |
|
|
VRAY
498
PUT
DELISTED
ViewRay, Inc.
VRAY
| $440K | 0.02% |
50,000
| – | – |
|
|
MRNS
499
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $436K | 0.02% |
26,250
-11,250
| -30% | -$195K |
|
500
Thor Industries
THO
$3.9B
| $427K | 0.02% |
7,300
+3,800
| +109% | +$231K |
|
Similar funds
ASRS
PP
VMPIC
BCIM
BBA
FCM
AIMCA
Caption Management's Q2 2019 Portfolio in Review
As of Q2 2019, Caption Management held 935 positions worth $1.99B, up 9.5% from $1.81B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Caption Management deployed $156M of net new capital in Q2 2019, opening 395 new positions and adding to 92 existing holdings. Its largest new stake was Spark Therapeutics, Inc. Common Stock: 78,000 shares worth $7.99M.
By sector, the portfolio is most concentrated in Healthcare at 3% of assets, down from 3.9% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $12.6M trimmed.
- Caption Management's largest Q2 2019 buy was Spark Therapeutics, Inc. Common Stock: 78,000 shares worth $7.99M.
- Caption Management added most to Crocs in Q2 2019, an estimated $5.07M increase.
- Caption Management's biggest Q2 2019 reduction was Bristol-Myers Squibb, cutting an estimated $12.6M.
- Caption Management fully exited iShares MSCI Saudi Arabia ETF in Q2 2019, selling an estimated $8.32M.
- Caption Management's ten largest holdings make up 16% of its $1.99B portfolio in Q2 2019.
- Caption Management opened 395 new positions and closed 294 in Q2 2019.
- Caption Management's portfolio value rose 9.5% quarter-over-quarter to $1.99B.
Based on Caption Management's 13F filing for Q2 2019, filed 13 Aug 2019.